ZYME Q4 2017 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$50M+2143.3% YoY

Gross Profit

$38M76.0% margin

Operating Income

$33M66.6% margin

Net Income

$33M65.4% margin

EPS (Diluted)

$1.28

QoQ Revenue Growth

+41976.5%

Cash Flow

Operating Cash Flow

$39M

Free Cash Flow

$39M

Stock-Based Comp.

$458,000

Balance Sheet

Total Assets

$132M

Total Liabilities

$16M

Stockholders' Equity

$116M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50M	$2M	+2143.3%
Gross Profit	$38M	-$5M	+801.9%
Operating Income	$33M	-$11M	+416.3%
Net Income	$33M	-$11M	+390.3%